AMPY vs IMPP

The company exhibits severe financial distress based on a Piotroski F-Score of 2/9, indicating weak financial health. Despite a low Price/Book of 0.49 and a forward P/E below sector average, persistent negative earnings surprises, declining revenue, and negative profit margin undermine valuation appeal. Operating margin and gross margin appear healthy but are inconsistent with overall profitability, which remains negative. The lack of Altman Z-Score and intrinsic value metrics, combined with deteriorating earnings trends and bearish technicals, suggests high risk.

IMPP exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a massive valuation gap, trading at $4.25 against a Graham Number of $20.12 and an Intrinsic Value of $38.05. The company is experiencing hyper-growth, with YoY revenue up 95.10% and earnings up 257.30%, while maintaining a highly liquid balance sheet (Current Ratio 11.99). Despite a bearish technical trend and low insider sentiment, the fundamental data suggests a deep-value opportunity with strong operational momentum. The consistent earnings beats (4/4) further validate the growth trajectory.